Clinical Trial Update: Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II) [Phase 1]

View source ↗

Summary

University of California, San Diego is conducting a Phase 1/2 clinical trial to test CT1-DAP001, human iPS cell-derived dopaminergic progenitors, for Parkinson'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• CT1-DAP001

Snippet

Sponsor: University of California, San Diego | Conditions: PD - Parkinson's Disease | Phase 1 | Status: RECRUITING